APO Research
Talk to an analyst

APO RESEARCH · REPORT

Peramivir

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Peramivir Industry Growth and Trends Forecast to 2032

2 January 2026104 pages

Choose your research edition.

Industry ResearchPeramivir Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Peramivir Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Peramivir Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Peramivir Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Peramivir Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Peramivir market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Peramivir is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Peramivir is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Peramivir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Peramivir include BioCryst Pharmaceuticals, Green Cross Pharma, Hikma Pharmaceuticals, Moksha8 Pharma, NeoPharm, NT Pharma, SCOLR Pharma, Hunan Nucien Pharmaceutical Co., Ltd. and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Peramivir market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Peramivir market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Peramivir market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Peramivir.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Peramivir market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Peramivir Market by Company

BioCryst Pharmaceuticals

Green Cross Pharma

Hikma Pharmaceuticals

Moksha8 Pharma

NeoPharm

NT Pharma

SCOLR Pharma

Hunan Nucien Pharmaceutical Co., Ltd.

Merck

Shionogi Co.

Peramivir Segment by Type

Solution

Solid

Peramivir Segment by Application

Influenza A Treatment

Influenza B Treatment

Peramivir Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peramivir market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Peramivir and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peramivir.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Peramivir manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Peramivir in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Solution Table 2. Major Company of Solid Table 3. Global Peramivir Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Peramivir Sales by Type (2021-2026) & (Tons) Table 5. Global Peramivir Sales Market Share in Volume by Type (2021-2026) Table 6. Global Peramivir Sales by Type (2021-2026) & (US$ Million) Table 7. Global Peramivir Sales Market Share in Value by Type (2021-2026) Table 8. Global Peramivir Price by Type (2021-2026) & (US$/Kg) Table 9. Global Peramivir Sales by Type (2027-2032) & (Tons) Table 10. Global Peramivir Sales Market Share in Volume by Type (2027-2032) Table 11. Global Peramivir Sales by Type (2027-2032) & (US$ Million) Table 12. Global Peramivir Sales Market Share in Value by Type (2027-2032) Table 13. Global Peramivir Price by Type (2027-2032) & (US$/Kg) Table 14. North America Peramivir Sales by Type (2021-2026) & (Tons) Table 15. North America Peramivir Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Peramivir Sales by Type (2021-2026) & (Tons) Table 17. Europe Peramivir Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Peramivir Sales by Type (2021-2026) & (Tons) Table 19. Asia-Pacific Peramivir Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Peramivir Sales by Type (2021-2026) & (Tons) Table 21. Latin America Peramivir Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Peramivir Sales by Type (2021-2026) & (Tons) Table 23. Middle East and Africa Peramivir Sales by Type (2021-2026) & (US$ Million) Table 24. Peramivir Industry Trends Table 25. Peramivir Industry Drivers Table 26. Peramivir Industry Opportunities and Challenges Table 27. Peramivir Industry Restraints Table 28. Global Peramivir Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Peramivir Revenue Market Share by Company (2021-2026) Table 30. Global Peramivir Sales by Company (2021-2026) & (Tons) Table 31. Global Peramivir Sales Share by Company (2021-2026) Table 32. Global Peramivir Market Price by Company (2021-2026) & (US$/Kg) Table 33. Global Peramivir Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Peramivir Major Company Production Sites and Headquarters Table 35. Global Peramivir Company, Product Type & Application Table 36. Global Peramivir Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Peramivir by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Peramivir Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Peramivir Sales by Region (2021-2026) & (Tons) Table 41. Global Peramivir Sales Market Share in Volume by Region (2021-2026) Table 42. Global Peramivir Sales by Region (2021-2026) & (US$ Million) Table 43. Global Peramivir Sales Market Share in Value by Region (2021-2026) Table 44. Global Peramivir Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 45. Global Peramivir Sales by Region (2027-2032) & (Tons) Table 46. Global Peramivir Sales Market Share in Volume by Region (2027-2032) Table 47. Global Peramivir Sales by Region (2027-2032) & (US$ Million) Table 48. Global Peramivir Sales Market Share in Value by Region (2027-2032) Table 49. Global Peramivir Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2027-2032) Table 50. Global Peramivir Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Peramivir Sales by Application (2021-2026) & (Tons) Table 52. Global Peramivir Sales Market Share in Volume by Application (2021-2026) Table 53. Global Peramivir Sales by Application (2021-2026) & (US$ Million) Table 54. Global Peramivir Sales Market Share in Value by Application (2021-2026) Table 55. Global Peramivir Price by Application (2021-2026) & (US$/Kg) Table 56. Global Peramivir Sales by Application (2027-2032) & (Tons) Table 57. Global Peramivir Sales Market Share in Volume by Application (2027-2032) Table 58. Global Peramivir Sales by Application (2027-2032) & (US$ Million) Table 59. Global Peramivir Sales Market Share in Value by Application (2027-2032) Table 60. Global Peramivir Price by Application (2027-2032) & (US$/Kg) Table 61. North America Peramivir Sales by Application (2021-2026) & (Tons) Table 62. North America Peramivir Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Peramivir Sales by Application (2021-2026) & (Tons) Table 64. Europe Peramivir Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Peramivir Sales by Application (2021-2026) & (Tons) Table 66. Asia-Pacific Peramivir Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Peramivir Sales by Application (2021-2026) & (Tons) Table 68. Latin America Peramivir Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Peramivir Sales by Application (2021-2026) & (Tons) Table 70. Middle East and Africa Peramivir Sales by Application (2021-2026) & (US$ Million) Table 71. BioCryst Pharmaceuticals Company Information Table 72. BioCryst Pharmaceuticals Business Overview Table 73. BioCryst Pharmaceuticals Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 74. BioCryst Pharmaceuticals Peramivir Product Portfolio Table 75. BioCryst Pharmaceuticals Recent Development Table 76. Green Cross Pharma Company Information Table 77. Green Cross Pharma Business Overview Table 78. Green Cross Pharma Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 79. Green Cross Pharma Peramivir Product Portfolio Table 80. Green Cross Pharma Recent Development Table 81. Hikma Pharmaceuticals Company Information Table 82. Hikma Pharmaceuticals Business Overview Table 83. Hikma Pharmaceuticals Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 84. Hikma Pharmaceuticals Peramivir Product Portfolio Table 85. Hikma Pharmaceuticals Recent Development Table 86. Moksha8 Pharma Company Information Table 87. Moksha8 Pharma Business Overview Table 88. Moksha8 Pharma Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 89. Moksha8 Pharma Peramivir Product Portfolio Table 90. Moksha8 Pharma Recent Development Table 91. NeoPharm Company Information Table 92. NeoPharm Business Overview Table 93. NeoPharm Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 94. NeoPharm Peramivir Product Portfolio Table 95. NeoPharm Recent Development Table 96. NT Pharma Company Information Table 97. NT Pharma Business Overview Table 98. NT Pharma Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 99. NT Pharma Peramivir Product Portfolio Table 100. NT Pharma Recent Development Table 101. SCOLR Pharma Company Information Table 102. SCOLR Pharma Business Overview Table 103. SCOLR Pharma Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 104. SCOLR Pharma Peramivir Product Portfolio Table 105. SCOLR Pharma Recent Development Table 106. Hunan Nucien Pharmaceutical Co., Ltd. Company Information Table 107. Hunan Nucien Pharmaceutical Co., Ltd. Business Overview Table 108. Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 109. Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Product Portfolio Table 110. Hunan Nucien Pharmaceutical Co., Ltd. Recent Development Table 111. Merck Company Information Table 112. Merck Business Overview Table 113. Merck Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 114. Merck Peramivir Product Portfolio Table 115. Merck Recent Development Table 116. Shionogi Co. Company Information Table 117. Shionogi Co. Business Overview Table 118. Shionogi Co. Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 119. Shionogi Co. Peramivir Product Portfolio Table 120. Shionogi Co. Recent Development Table 121. North America Peramivir Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 122. North America Peramivir Sales by Country (2021-2026) & (Tons) Table 123. North America Peramivir Sales Market Share by Country (2021-2026) Table 124. North America Peramivir Sales Forecast by Country (2027-2032) & (Tons) Table 125. North America Peramivir Sales Market Share Forecast by Country (2027-2032) Table 126. North America Peramivir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Peramivir Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Peramivir Market Share by Country (2021-2026) Table 129. North America Peramivir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Peramivir Market Share Forecast by Country (2027-2032) Table 131. Europe Peramivir Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 132. Europe Peramivir Sales by Country (2021-2026) & (Tons) Table 133. Europe Peramivir Sales Market Share by Country (2021-2026) Table 134. Europe Peramivir Sales Forecast by Country (2027-2032) & (Tons) Table 135. Europe Peramivir Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Peramivir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Peramivir Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Peramivir Market Share by Country (2021-2026) Table 139. Europe Peramivir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Peramivir Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Peramivir Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Peramivir Sales by Country (2021-2026) & (Tons) Table 143. Asia-Pacific Peramivir Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Peramivir Sales Forecast by Country (2027-2032) & (Tons) Table 145. Asia-Pacific Peramivir Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Peramivir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Peramivir Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Peramivir Market Share by Country (2021-2026) Table 149. Asia-Pacific Peramivir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Peramivir Market Share Forecast by Country (2027-2032) Table 151. Latin America Peramivir Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 152. Latin America Peramivir Sales by Country (2021-2026) & (Tons) Table 153. Latin America Peramivir Sales Market Share by Country (2021-2026) Table 154. Latin America Peramivir Sales Forecast by Country (2027-2032) & (Tons) Table 155. Latin America Peramivir Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Peramivir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Peramivir Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Peramivir Market Share by Country (2021-2026) Table 159. Latin America Peramivir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Peramivir Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Peramivir Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Peramivir Sales by Country (2021-2026) & (Tons) Table 163. Middle East and Africa Peramivir Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Peramivir Sales Forecast by Country (2027-2032) & (Tons) Table 165. Middle East and Africa Peramivir Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Peramivir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Peramivir Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Peramivir Market Share by Country (2021-2026) Table 169. Middle East and Africa Peramivir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Peramivir Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Peramivir Distributors List Table 174. Peramivir Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Peramivir Image Figure 2. Global Peramivir Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Peramivir Market Size (2021-2032) & (US$ Million) Figure 4. Global Peramivir Sales (2021-2032) & (Tons) Figure 5. Solution Image Figure 6. Global Solution Sales YoY Growth (2021-2032) & (Tons) Figure 7. Solid Image Figure 8. Global Solid Sales YoY Growth (2021-2032) & (Tons) Figure 9. Global Peramivir Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Peramivir Market Share by Type 2025 VS 2032 Figure 11. North America Peramivir Sales Market Share in Volume by Type in 2025 Figure 12. North America Peramivir Sales Market Share in Value by Type in 2025 Figure 13. Europe Peramivir Sales Market Share in Volume by Type in 2025 Figure 14. Europe Peramivir Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Peramivir Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Peramivir Sales Market Share in Value by Type in 2025 Figure 17. Latin America Peramivir Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Peramivir Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Peramivir Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Peramivir Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Peramivir Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Influenza A Treatment Image Figure 24. Global Influenza A Treatment Sales YoY Growth (2021-2032) & (Tons) Figure 25. Influenza B Treatment Image Figure 26. Global Influenza B Treatment Sales YoY Growth (2021-2032) & (Tons) Figure 27. Global Peramivir Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Peramivir Market Share by Application 2025 VS 2032 Figure 29. North America Peramivir Sales Market Share in Volume by Application in 2025 Figure 30. North America Peramivir Sales Market Share in Value by Application in 2025 Figure 31. Europe Peramivir Sales Market Share in Volume by Application in 2025 Figure 32. Europe Peramivir Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Peramivir Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Peramivir Sales Market Share in Value by Application in 2025 Figure 35. Latin America Peramivir Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Peramivir Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Peramivir Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Peramivir Sales Market Share in Value by Application in 2025 Figure 39. North America Peramivir Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 40. North America Peramivir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Peramivir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Peramivir Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Peramivir Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 44. Europe Peramivir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Peramivir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Peramivir Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Peramivir Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 48. Asia-Pacific Peramivir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Peramivir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Peramivir Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Peramivir Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 52. Latin America Peramivir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Peramivir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Peramivir Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Peramivir Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 56. Middle East and Africa Peramivir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Peramivir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Peramivir Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Peramivir Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Peramivir Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Solution
  • Solid
Applications
  • Influenza A Treatment
  • Influenza B Treatment
Companies covered
  • BioCryst Pharmaceuticals
  • Green Cross Pharma
  • Hikma Pharmaceuticals
  • Moksha8 Pharma
  • NeoPharm
  • NT Pharma
  • SCOLR Pharma
  • Hunan Nucien Pharmaceutical Co., Ltd.
  • Merck
  • Shionogi Co.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Peramivir Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Peramivir Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Peramivir Market by Type
  6. 1.3.1 Solution
  7. 1.3.2 Solid
  8. 1.4 Global Peramivir Market Size by Type
  9. 1.4.1 Global Peramivir Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Peramivir Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Peramivir Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Peramivir Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Peramivir Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Peramivir Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Peramivir Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Peramivir Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Peramivir Industry Trends
  2. 2.2 Peramivir Industry Drivers
  3. 2.3 Peramivir Industry Opportunities and Challenges
  4. 2.4 Peramivir Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Peramivir Revenue (2021-2026)
  2. 3.2 Global Top Players by Peramivir Sales (2021-2026)
  3. 3.3 Global Top Players by Peramivir Price (2021-2026)
  4. 3.4 Global Peramivir Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Peramivir Major Company Production Sites & Headquarters
  6. 3.6 Global Peramivir Company, Product Type & Application
  7. 3.7 Global Peramivir Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Peramivir Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Peramivir Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Peramivir Tier 1, Tier 2, and Tier 3
4 Peramivir Regional Status and Outlook
  1. 4.1 Global Peramivir Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Peramivir Historic Market Size by Region
  3. 4.2.1 Global Peramivir Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Peramivir Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Peramivir Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Peramivir Forecasted Market Size by Region
  7. 4.3.1 Global Peramivir Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Peramivir Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Peramivir Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Peramivir by Application
  1. 5.1 Peramivir Market by Application
  2. 5.1.1 Influenza A Treatment
  3. 5.1.2 Influenza B Treatment
  4. 5.2 Global Peramivir Market Size by Application
  5. 5.2.1 Global Peramivir Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Peramivir Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Peramivir Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Peramivir Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Peramivir Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Peramivir Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Peramivir Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Peramivir Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 BioCryst Pharmaceuticals
  2. 6.1.1 BioCryst Pharmaceuticals Company Information
  3. 6.1.2 BioCryst Pharmaceuticals Business Overview
  4. 6.1.3 BioCryst Pharmaceuticals Peramivir Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 BioCryst Pharmaceuticals Peramivir Product Portfolio
  6. 6.1.5 BioCryst Pharmaceuticals Recent Developments
  7. 6.2 Green Cross Pharma
  8. 6.2.1 Green Cross Pharma Company Information
  9. 6.2.2 Green Cross Pharma Business Overview
  10. 6.2.3 Green Cross Pharma Peramivir Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Green Cross Pharma Peramivir Product Portfolio
  12. 6.2.5 Green Cross Pharma Recent Developments
  13. 6.3 Hikma Pharmaceuticals
  14. 6.3.1 Hikma Pharmaceuticals Company Information
  15. 6.3.2 Hikma Pharmaceuticals Business Overview
  16. 6.3.3 Hikma Pharmaceuticals Peramivir Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Hikma Pharmaceuticals Peramivir Product Portfolio
  18. 6.3.5 Hikma Pharmaceuticals Recent Developments
  19. 6.4 Moksha8 Pharma
  20. 6.4.1 Moksha8 Pharma Company Information
  21. 6.4.2 Moksha8 Pharma Business Overview
  22. 6.4.3 Moksha8 Pharma Peramivir Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Moksha8 Pharma Peramivir Product Portfolio
  24. 6.4.5 Moksha8 Pharma Recent Developments
  25. 6.5 NeoPharm
  26. 6.5.1 NeoPharm Company Information
  27. 6.5.2 NeoPharm Business Overview
  28. 6.5.3 NeoPharm Peramivir Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 NeoPharm Peramivir Product Portfolio
  30. 6.5.5 NeoPharm Recent Developments
  31. 6.6 NT Pharma
  32. 6.6.1 NT Pharma Company Information
  33. 6.6.2 NT Pharma Business Overview
  34. 6.6.3 NT Pharma Peramivir Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 NT Pharma Peramivir Product Portfolio
  36. 6.6.5 NT Pharma Recent Developments
  37. 6.7 SCOLR Pharma
  38. 6.7.1 SCOLR Pharma Company Information
  39. 6.7.2 SCOLR Pharma Business Overview
  40. 6.7.3 SCOLR Pharma Peramivir Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 SCOLR Pharma Peramivir Product Portfolio
  42. 6.7.5 SCOLR Pharma Recent Developments
  43. 6.8 Hunan Nucien Pharmaceutical Co., Ltd.
  44. 6.8.1 Hunan Nucien Pharmaceutical Co., Ltd. Company Information
  45. 6.8.2 Hunan Nucien Pharmaceutical Co., Ltd. Business Overview
  46. 6.8.3 Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Product Portfolio
  48. 6.8.5 Hunan Nucien Pharmaceutical Co., Ltd. Recent Developments
  49. 6.9 Merck
  50. 6.9.1 Merck Company Information
  51. 6.9.2 Merck Business Overview
  52. 6.9.3 Merck Peramivir Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Merck Peramivir Product Portfolio
  54. 6.9.5 Merck Recent Developments
  55. 6.10 Shionogi Co.
  56. 6.10.1 Shionogi Co. Company Information
  57. 6.10.2 Shionogi Co. Business Overview
  58. 6.10.3 Shionogi Co. Peramivir Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Shionogi Co. Peramivir Product Portfolio
  60. 6.10.5 Shionogi Co. Recent Developments
7 North America by Country
  1. 7.1 North America Peramivir Sales by Country
  2. 7.1.1 North America Peramivir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Peramivir Sales by Country (2021-2026)
  4. 7.1.3 North America Peramivir Sales Forecast by Country (2027-2032)
  5. 7.2 North America Peramivir Market Size by Country
  6. 7.2.1 North America Peramivir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Peramivir Market Size by Country (2021-2026)
  8. 7.2.3 North America Peramivir Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Peramivir Sales by Country
  2. 8.1.1 Europe Peramivir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Peramivir Sales by Country (2021-2026)
  4. 8.1.3 Europe Peramivir Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Peramivir Market Size by Country
  6. 8.2.1 Europe Peramivir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Peramivir Market Size by Country (2021-2026)
  8. 8.2.3 Europe Peramivir Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Peramivir Sales by Country
  2. 9.1.1 Asia-Pacific Peramivir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Peramivir Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Peramivir Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Peramivir Market Size by Country
  6. 9.2.1 Asia-Pacific Peramivir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Peramivir Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Peramivir Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Peramivir Sales by Country
  2. 10.1.1 South America Peramivir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Peramivir Sales by Country (2021-2026)
  4. 10.1.3 South America Peramivir Sales Forecast by Country (2027-2032)
  5. 10.2 South America Peramivir Market Size by Country
  6. 10.2.1 South America Peramivir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Peramivir Market Size by Country (2021-2026)
  8. 10.2.3 South America Peramivir Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Peramivir Sales by Country
  2. 11.1.1 Middle East and Africa Peramivir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Peramivir Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Peramivir Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Peramivir Market Size by Country
  6. 11.2.1 Middle East and Africa Peramivir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Peramivir Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Peramivir Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Peramivir Value Chain Analysis
  2. 12.1.1 Peramivir Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Peramivir Production Mode & Process
  7. 12.2 Peramivir Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Peramivir Distributors
  10. 12.2.3 Peramivir Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst